Industry & Policy News

[News Medical Life Sciences] The National Institutes of Health has awarded $2.6 million to a Virginia Tech team over five years for a study of high frequency irreversible electroporation for tumor ablation and immune system activation in cases of pancreatic cancer.

[Fox Chase Cancer Center] Dr. Sanjay Reddy, an Associate Professor in the Department of Surgical Oncology at Fox Chase Cancer Center, received an Investigator Initiated Clinical Trial grant from Fox Chase’s Office of Sponsored Research to study the impact of diet and lifestyle factors on pancreatic ductal adenocarcinoma, or PDAC, the most common form of pancreatic cancer.

[Kings College London] Researchers from Kings College London and University College London have been awarded £500,000 from Cancer Research UK’s Multidisciplinary Project Award, to develop a novel PET imaging reagent for CAR T cell in vivo tracking.

[Johnson & Johnson] The Janssen Pharmaceutical Companies of Johnson & Johnson announced that the US FDA has granted accelerated approval of TALVEY™.

[Fierce Biotech] Sanofi will be the inaugural partner for the Scleroderma Research Foundation’s new clinical trial initiative to advance treatments for the rare autoimmune disorder of the skin and organs.

[Southern Illinois University Carbondale] A researcher at Southern Illinois University Carbondale will use a $445,500 federal grant to explore ways of turning off a genetic switch that allows rare but devasting cancer to progress in children.